BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15362740)

  • 21. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas.
    Teh M; Wee A; Raju GC
    Cancer; 1994 Sep; 74(5):1542-5. PubMed ID: 7520348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor DNA content in gallbladder carcinoma.
    Sato Y; Tanaka J; Koyama K; van Gulik TM; Lygidakis NJ; van der Heyde MN
    Hepatogastroenterology; 1993 Aug; 40(4):375-9. PubMed ID: 8406309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neoplasms and dysplasias of the gallbladder and their relationship with lithiasis. A case-control clinicopathological study].
    Martínez-Guzmán G; de la Rosa-Bayón J
    Rev Gastroenterol Mex; 1998; 63(2):82-8. PubMed ID: 10068733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P53 protein expression in pancreatic tumors and its relationship to clinicopathological factors and prognosis.
    Aizawa S; Sasaki M; Wada R; Koyama M; Yagihashi S
    J Surg Oncol; 1996 Aug; 62(4):279-83. PubMed ID: 8691842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of primary carcinoma of the gallbladder--report of 33 cases].
    Liu XL
    Zhonghua Zhong Liu Za Zhi; 1986 Jan; 8(1):58-60. PubMed ID: 3732026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile.
    Yokoyama N; Hitomi J; Watanabe H; Ajioka Y; Pruyas M; Serra I; Shirai Y; Hatakeyama K
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):297-301. PubMed ID: 9568784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanism involved in increased expression of sialyl Lewis antigens in ductal carcinoma of the pancreas.
    Nakamori S; Nishihara S; Ikehara Y; Nagano H; Dono K; Sakon M; Narimatsu H; Monden M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):425-32. PubMed ID: 10606190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic status of p53 gene mutation in canine mammary carcinoma.
    Wakui S; Muto T; Yokoo K; Yokoo R; Takahashi H; Masaoka T; Hano H; Furusato M
    Anticancer Res; 2001; 21(1B):611-6. PubMed ID: 11299814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of the surgical treatment of gallbladder carcinomas].
    Rassek D; Straub D; Sons HU; Stock W
    Chirurg; 1985 Jul; 56(7):440-4. PubMed ID: 4042758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gallbladder carcinoma--an unexpected finding after laparoscopic cholecystectomy].
    Hohaus T; Hellmich G; Freitag M; Ludwig K
    Zentralbl Chir; 1998; 123 Suppl 2():80-3. PubMed ID: 9622876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Port site metastases following laparoscopic cholecystectomy for unsuspected carcinoma of the gallbladder.
    Reber PU; Baer HU; Patel AG; Schmied B; Büchler MW
    Z Gastroenterol; 1998 Oct; 36(10):901-7. PubMed ID: 9846369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced cell kinetics, p53 accumulation and high p21WAF1 expression in chronic cholecystitis: comparison with background mucosa of gallbladder carcinomas.
    Yanagisawa N; Mikami T; Koike M; Okayasu I
    Histopathology; 2000 Jan; 36(1):54-61. PubMed ID: 10632753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.
    Hu YX; Watanabe H; Ohtsubo K; Yamaguchi Y; Ha A; Okai T; Sawabu N
    Clin Cancer Res; 1997 Sep; 3(9):1473-7. PubMed ID: 9815833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Videolaparoscopy and carcinoma of the gallbladder].
    Sarli L; Pavlidis C; Costi R; Contini S; Sgobba G; Roncoroni L
    Chir Ital; 2000; 52(6):655-61. PubMed ID: 11200000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA ploidy patterns in gallbladder adenocarcinoma.
    Yamamoto M; Oda N; Tahara E
    Jpn J Clin Oncol; 1990 Mar; 20(1):83-6. PubMed ID: 2319702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival.
    Diamantis I; Karamitopoulou E; Perentes E; Zimmermann A
    Hepatology; 1995 Sep; 22(3):774-9. PubMed ID: 7657282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gallbladder carcinoma. Personal case histories].
    Interlandi A; Andreotti A; Chiavilli S
    Minerva Chir; 1999; 54(7-8):491-4. PubMed ID: 10528481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of histologic classification of carcinoma of the gallbladder.
    Bivins BA; Meeker WR; Griffen WO
    Am Surg; 1975 Mar; 41(3):121-4. PubMed ID: 1119751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoma of the gallbladder.
    Klamer TW; Max MH
    Surg Gynecol Obstet; 1983 May; 156(5):641-5. PubMed ID: 6845128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Carcinoma in situ of the gallbladder. The prognostic and therapeutic implications].
    Gómez Freijoso C; Acea Nebril B; Fraguela Mariña J; Taboada Filgueira L; Freire Rodríguez D; Aguirrezabalaga González J
    Gastroenterol Hepatol; 1995 Nov; 18(9):457-9. PubMed ID: 8521221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.